1.
Clin Case Rep
; 9(9): e04646, 2021 Sep.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34567551
RESUMEN
This is the first case of a patient taking aprepitant for a post-acute COVID-19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome.